Demo Data from VLDB 2026 / reviewers in the wild / expert
Christopher D. Fjell
dblp:43/2567
· DBLP profile ↗
1ranked-venue papers
1as first author
0since 2021 · last 2007
0000-0001-6304-2628ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 4 heaviest of 5, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery › peptide drug discovery
antimicrobial peptide discovery |
0.1 | 1 | 2007 | AMPer: a database and an automated discovery tool for antimicrobial peptides · Bioinform. 2007 |
Bioinformatics and computational biology › sequence analysis
profile hidden markov model |
0.1 | 1 | 2007 | AMPer: a database and an automated discovery tool for antimicrobial peptides · Bioinform. 2007 |
Bioinformatics and computational biology
protein function prediction |
0.1 | 1 | 2007 | AMPer: a database and an automated discovery tool for antimicrobial peptides · Bioinform. 2007 |
Bioinformatics and computational biology
sequence analysis |
0.1 | 1 | 2007 | AMPer: a database and an automated discovery tool for antimicrobial peptides · Bioinform. 2007 |
Methods — techniques the papers use, named apart from their topics
sequence clustering · 0.1hidden markov model · 0.1
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2007 | AMPer: a database and an automated discovery tool for antimicrobial peptidesabstractMOTIVATION: Increasing antibiotics resistance in human pathogens represents a pressing public health issue worldwide for which novel antibiotic therapies based on antimicrobial peptides (AMPs) may offer one possible solution. In the current study, we utilized publicly available data on AMPs to construct hidden Markov models (HMMs) that enable recognition of individual classes of antimicrobials peptides (such as defensins, cathelicidins, cecropins, etc.) with up to 99% accuracy and can be used for discovering novel AMP candidates. RESULTS: HMM models for both mature peptides and propeptides were constructed. A total of 146 models for mature peptides and 40 for propeptides have been developed for individual AMP classes. These were created by clustering and analyzing AMP sequences available in the public sources and by consequent iterative scanning of the Swiss-Prot database for previously unknown gene-coded AMPs. As a result, an additional 229 additional AMPs have been identified from Swiss-Prot, and all but 34 could be associated with known antimicrobial activities according to the literature. The final set of 1045 mature peptides and 253 propeptides have been organized into the open-source AMPer database. AVAILABILITY: The developed HMM-based tools and AMP sequences can be accessed through the AMPer resource at http://www.cnbi2.com/cgi-bin/amp.pl Christopher D. Fjell, Robert E. W. Hancock, Artem Cherkasov |
Bioinform. | 1 |